Prosecution Insights
Last updated: November 13, 2026

Memed Diagnostics Ltd.

Technology area: Biotechnology & Pharmaceuticals

4 pending office actions • 3 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days

Analysis

Memed Diagnostics Ltd. has 4 pending office actions in the Biotechnology & Pharmaceuticals technology area. These actions are being handled by 4 distinct examiners across 3 distinct art units. This distribution shows a relatively broad prosecution effort for the company's diagnostic technologies. The use of 3 distinct art units suggests that the applications are categorized into several different technical groups, reflecting the diverse nature of the company's pharmaceutical and diagnostic innovations.

LY, KRISTINA ELISABETH is identified as the busiest examiner, though she only holds 1 pending office action. With 4 distinct examiners each managing a portion of the 4 pending office actions, the workload is evenly distributed among the individuals involved. This parity ensures that the portfolio's success is not tied to the decisions of a single examiner. However, the involvement of 4 distinct examiners means that practitioners must prepare for different sets of examination styles.

Practitioners managing this portfolio must navigate the requirements of 4 distinct examiners. The involvement of 3 distinct art units means that the prosecution strategy must be adapted to the specific standards of each group. Since LY, KRISTINA ELISABETH only holds 1 pending action, the individual influence of any one examiner is limited. This structure requires a coordinated effort to ensure consistency across the 4 pending office actions while respecting the nuances of the 3 distinct art units.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

4
Total Pending OAs
3
Non-Final OAs
1
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

0
Overdue
0
Due this week
2
Due this month
1
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Due ≤ 30 days (2)Due ≤ 60 days (1)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

2
Hard (50%)
1
Medium (25%)
1
Easy (25%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other1 (25%)
§103 only1 (25%)
§112 only1 (25%)
Multi-statute (no §101)1 (25%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

4
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

40 h
Manual time on pending OAs
8 h
Time saved (low, 20%)
14 h
Time saved (mid, 35%)
0.3 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
LY, KRISTINA ELISABETH 1 37.5% +100.0%
SALVOZA, M FRANCO G 1 68.0% +30.7%
ALLEN, MICHAEL D 1 31.8% +48.7%
QIAN, CELINE X 1 47.5% +17.4%

Hard Cases (2)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
17916577 RNA MARKERS FOR DIAGNOSING INFECTIONS SALVOZA, M FRANCO G 34d
18272838 MARKERS FOR DIAGNOSING INFECTIONS LY, KRISTINA ELISABETH —

Interview Candidates (4)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.

App #TitleExaminerDue in
17796284 METHODS OF DIAGNOSING AND CLASSIFYING VIRAL INFECTIONS QIAN, CELINE X 14d
17955599 RNA DETERMINANTS FOR DISTINGUISHING BETWEEN BACTERIAL AND VIRAL INFECTIONS ALLEN, MICHAEL D 28d
17916577 RNA MARKERS FOR DIAGNOSING INFECTIONS SALVOZA, M FRANCO G 34d
18272838 MARKERS FOR DIAGNOSING INFECTIONS LY, KRISTINA ELISABETH —

Top Art Units

Art UnitApps
1671 2
1672 1
1637 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18272838 MARKERS FOR DIAGNOSING INFECTIONS LY, KRISTINA ELISABETH 1671 §103§112 Non-Final OA — Pending Jul 18, 2023
17916577 RNA MARKERS FOR DIAGNOSING INFECTIONS SALVOZA, M FRANCO G 1672 §101§112 Final Rejection 34d Pending Oct 02, 2022
17955599 RNA DETERMINANTS FOR DISTINGUISHING BETWEEN BACTERIAL AND VIRAL INFECTIONS ALLEN, MICHAEL D 1671 §112 Non-Final OA 28d Pending Sep 29, 2022
17796284 METHODS OF DIAGNOSING AND CLASSIFYING VIRAL INFECTIONS QIAN, CELINE X 1637 §103 Non-Final OA 14d Pending Jul 29, 2022

Managing Memed Diagnostics Ltd.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Memed Diagnostics Ltd. have?

Memed Diagnostics Ltd. has 4 pending office actions as of November 2026, spread across 3 art units and 4 examiners.

Which USPTO examiner handles the most Memed Diagnostics Ltd. applications?

Kristina Elisabeth Ly has the most, with 1 of Memed Diagnostics Ltd.'s pending office actions.

What technology area are Memed Diagnostics Ltd.'s patent applications in?

Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month